Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioNTech SE (BNTX)Business Wire • 01/30/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of BioNTech SE (BNTX) InvestorsBusiness Wire • 01/29/24
BNTX STOCK NEWS: Shareholders with Significant Losses Should Contact Robbins LLP for Information About the BioNTech SE Class Action LawsuitBusiness Wire • 01/26/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BioNTech SE (BNTX) InvestorsBusiness Wire • 01/26/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of BioNTech SE (BNTX) on Behalf of InvestorsBusiness Wire • 01/25/24
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the FirmAccesswire • 01/25/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of BioNTech SE (BNTX) on Behalf of InvestorsBusiness Wire • 01/24/24
DEADLINE ACTION REMINDER: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the FirmAccesswire • 01/24/24
ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTXPRNewsWire • 01/23/24
SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioNTech SE (BNTX) Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 01/23/24
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses In Excess of $100,000 to Contact the FirmAccesswire • 01/22/24
BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast CancerGlobeNewsWire • 01/22/24
BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Business Wire • 01/22/24
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against BioNTech SEPRNewsWire • 01/21/24
BNTX ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against BioNTech SE (BNTX)Business Wire • 01/20/24
The Law Offices of Frank R. Cruz Announces Investigation of BioNTech SE (BNTX) on Behalf of InvestorsBusiness Wire • 01/19/24
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses In Excess of $100,000 to Contact the FirmAccesswire • 01/19/24
BioNTech SE (BNTX) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Filed Against BioNTech SEBusiness Wire • 01/18/24
BIONTECH INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their OptionsPRNewsWire • 01/18/24
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses In Excess of $100,000 to Contact the FirmAccesswire • 01/17/24
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTXPRNewsWire • 01/17/24
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BNTXBusiness Wire • 01/16/24
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product CandidatesPRNewsWire • 01/10/24
